Repare Therapeutics (RPTX) Competitors $1.37 -0.07 (-4.86%) Closing price 07/3/2025 01:26 PM EasternExtended Trading$1.38 +0.01 (+0.66%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPTX vs. ACB, NGNE, TVRD, BTMD, SLRN, TVGN, CGC, PRQR, NBTX, and YMABShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Aurora Cannabis (ACB), Neurogene (NGNE), Tvardi Therapeutics (TVRD), biote (BTMD), Acelyrin (SLRN), Semper Paratus Acquisition (TVGN), Canopy Growth (CGC), ProQR Therapeutics (PRQR), Nanobiotix (NBTX), and Y-mAbs Therapeutics (YMAB). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. Its Competitors Aurora Cannabis Neurogene Tvardi Therapeutics biote Acelyrin Semper Paratus Acquisition Canopy Growth ProQR Therapeutics Nanobiotix Y-mAbs Therapeutics Repare Therapeutics (NASDAQ:RPTX) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Is RPTX or ACB more profitable? Aurora Cannabis has a net margin of 1.32% compared to Repare Therapeutics' net margin of 0.00%. Aurora Cannabis' return on equity of 0.13% beat Repare Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Repare TherapeuticsN/A -78.12% -67.11% Aurora Cannabis 1.32%0.13%0.10% Does the media prefer RPTX or ACB? In the previous week, Repare Therapeutics had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Repare Therapeutics and 2 mentions for Aurora Cannabis. Repare Therapeutics' average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.12 indicating that Repare Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repare Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, RPTX or ACB? Aurora Cannabis has higher revenue and earnings than Repare Therapeutics. Repare Therapeutics is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRepare Therapeutics$53.48M1.10-$84.69M-$3.01-0.46Aurora Cannabis$246.72M1.04$1.63M$0.1141.59 Do insiders and institutionals hold more shares of RPTX or ACB? 85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 11.5% of Repare Therapeutics shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, RPTX or ACB? Repare Therapeutics has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Do analysts prefer RPTX or ACB? Repare Therapeutics presently has a consensus price target of $4.50, suggesting a potential upside of 228.47%. Given Repare Therapeutics' higher possible upside, analysts plainly believe Repare Therapeutics is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Repare Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 SummaryAurora Cannabis beats Repare Therapeutics on 9 of the 16 factors compared between the two stocks. Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RPTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.76M$2.92B$5.56B$9.05BDividend YieldN/A2.44%5.24%3.99%P/E RatioN/A8.2819.9620.26Price / Sales1.10283.26419.56119.26Price / CashN/A41.7026.2128.59Price / Book0.387.538.035.65Net Income-$84.69M-$55.14M$3.18B$249.15M7 Day Performance-1.44%4.61%2.93%3.28%1 Month Performance-6.80%0.90%1.72%3.95%1 Year Performance-56.78%5.40%34.39%20.98% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics2.1022 of 5 stars$1.37-4.9%$4.50+228.5%-56.8%$61.76M$53.48M0.00180News CoverageACBAurora Cannabis0.1956 of 5 stars$4.24+2.2%N/A-5.1%$233.29M$246.72M38.551,130NGNENeurogene3.8085 of 5 stars$14.95-7.5%$46.17+208.8%-41.3%$230.48M$930K-3.4490News CoveragePositive NewsTVRDTvardi TherapeuticsN/A$23.33-5.2%$71.50+206.5%N/A$230.37M$7.14M0.0080BTMDbiote3.0897 of 5 stars$4.02-4.3%$8.00+99.0%-43.0%$229.78M$197.19M6.59194News CoveragePositive NewsSLRNAcelyrinN/A$2.27flat$9.60+322.9%N/A$229.17MN/A-0.92135TVGNSemper Paratus Acquisition3.9852 of 5 stars$1.25+0.8%$10.00+700.0%+77.9%$228.03MN/A0.003Positive NewsCGCCanopy Growth2.8387 of 5 stars$1.22flat$2.00+63.9%-79.6%$224.32M$225.65M-0.303,150Positive NewsPRQRProQR Therapeutics2.1281 of 5 stars$2.04flat$8.00+292.2%+26.1%$214.63M$20.46M-5.83180News CoverageNBTXNanobiotix1.6861 of 5 stars$4.73+4.4%$8.00+69.1%-8.2%$213.34M$39.18M0.00100Positive NewsGap UpYMABY-mAbs Therapeutics3.1314 of 5 stars$4.51-4.0%$15.60+245.9%-62.2%$212.83M$87.68M-7.05150News Coverage Related Companies and Tools Related Companies Aurora Cannabis Alternatives Neurogene Alternatives Tvardi Therapeutics Alternatives biote Alternatives Acelyrin Alternatives Semper Paratus Acquisition Alternatives Canopy Growth Alternatives ProQR Therapeutics Alternatives Nanobiotix Alternatives Y-mAbs Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPTX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredGold buying hits 4-year highThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPTX Stock Alerts